Nutex Health Inc. Q3 FY2024 earnings call

Revenue and Volume Growth

• Total revenue for Q3 2024 was $78.8 million, up 26% y-o-y. Net loss was $8.8 million, but adjusted EBITDA was $13.5 million, a 938% increase from Q3 2023.

Operational Efficiencies

• Internal coding, billing, and collections team adapting to No Surprises Act claims, leading to improved reimbursement per patient.

Hospital Expansions

• Opened 4 de novo hospitals in 2023, with 2 more planned to open by the end of 2024. Working on the 2025-2027 hospital pipeline.

Service Expansion

• Continuing to expand services in mature hospitals, including adding new specialties and enhancing current offerings to meet community needs.

Reimbursement with Insurers

• Adapting to No Surprises Act claims, moving through open negotiation to arbitration if needed, with industry data showing high win rates for providers.

Operational Efficiency Initiatives

• Implementing software for labor, supply chain, and contract services to control costs, with plans for a labor suite including scheduling and analytics tools.

For the third quarter ended September 30, 2024, Nutex Health's Hospital division reported total revenue of $78.8 million, a 26% increase from $62.7 million in the same period of 2023. Hospital division visits were 41,668, an 11.3% increase over Q3 2023, with mature hospitals (opened prior to December 31, 2021) seeing revenue up 20.7% and visits up 3.8%. The Population Health division had revenue of $7.1 million in Q3 2024, down from $8.1 million in Q3 2023 due to the divestiture of two small entities within the division.

Hospital Openings

• On track to open 2-4 hospitals per year. 2024 has seen 4 opened, with 2 more planned by end of 2024. 2025 is planned to have 4 hospital openings, with cadence depending on construction timelines.

Service Expansion

• Continuing to introduce new services tailored to community needs, such as behavioral health and procedures, to meet local healthcare demands.

• Weather Impact: Hurricane in Florida affected the timing of one hospital opening, though hospitals are built to withstand such events.
• Variable Interest Entities: Two hospitals in Albuquerque still on the balance sheet, but the bank intends to remove them by the end of 2024.
• NSA Process Uncertainty: Outcomes of arbitration processes are pending, with potential impact on near-term revenue as results are expected in Q4/early 2025.

Q: Thoughts on Q4 volume and hospital openings?

A: Anticipates higher Q4 volume due to seasonality, with two hospitals opening in November and December.

Q: CapEx outlook?

A: CapEx expected to increase as new facilities open, with equipment needed months ahead of opening dates.

Q: NSA arbitration progress?

A: Arbitration process started in June, with industry data showing high win rates (70-80% for providers), and results expected in Q4/early 2025.

Q: 2025 hospital cadence?

A: Planning 4 hospitals in 2025, with one opening in Q1/Q2 and three by the end of 2025.

Q: New services and cost savings?

A: Focus on labor, supply chain, and contract services software to optimize costs and introduce new community-tailored services like behavioral health and procedures.